JP2016520133A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520133A5
JP2016520133A5 JP2016517049A JP2016517049A JP2016520133A5 JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5 JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016517049 A JP2016517049 A JP 2016517049A JP 2016520133 A5 JP2016520133 A5 JP 2016520133A5
Authority
JP
Japan
Prior art keywords
group
alkyl
carbon atoms
alkoxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016517049A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520133A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/040286 external-priority patent/WO2014194226A2/en
Publication of JP2016520133A publication Critical patent/JP2016520133A/ja
Publication of JP2016520133A5 publication Critical patent/JP2016520133A5/ja
Pending legal-status Critical Current

Links

JP2016517049A 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物 Pending JP2016520133A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361829759P 2013-05-31 2013-05-31
US61/829,759 2013-05-31
US201361839609P 2013-06-26 2013-06-26
US61/839,609 2013-06-26
PCT/US2014/040286 WO2014194226A2 (en) 2013-05-31 2014-05-30 Methods of treatment and compositions with xanthine oxidase inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019034081A Division JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Publications (2)

Publication Number Publication Date
JP2016520133A JP2016520133A (ja) 2016-07-11
JP2016520133A5 true JP2016520133A5 (enExample) 2017-07-06

Family

ID=50983231

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016517049A Pending JP2016520133A (ja) 2013-05-31 2014-05-30 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019034081A Pending JP2019108356A (ja) 2013-05-31 2019-02-27 キサンチンオキシダーゼ阻害剤を用いた治療方法及びそれを含む組成物

Country Status (9)

Country Link
US (2) US20140357683A1 (enExample)
JP (2) JP2016520133A (enExample)
CN (1) CN105579037A (enExample)
CA (1) CA2913755A1 (enExample)
MX (1) MX2015016494A (enExample)
PH (1) PH12015502679A1 (enExample)
SG (2) SG11201509738RA (enExample)
TW (1) TW201536284A (enExample)
WO (1) WO2014194226A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3003237A1 (en) * 2015-10-28 2017-05-04 Sun Pharmaceutical Industries Limited Pharmaceutical compositions of dimethyl fumarate
CN105769766B (zh) * 2016-03-24 2018-07-06 长沙佰顺生物科技有限公司 一种托匹司他纳米乳及其制备方法
JP7108384B2 (ja) * 2016-07-13 2022-07-28 日本ケミファ株式会社 2-[3-シアノ-4-(2-メチルプロポキシ)フェニル]-4-メチルチアゾール-5-カルボン酸の口腔内崩壊錠
PT3484862T (pt) * 2016-07-18 2021-11-17 Arthrosi Therapeutics Inc Compostos, composições e métodos para o tratamento ou a prevenção de um sintoma associado a gota ou hiperuricemia
EP3890723A4 (en) 2018-12-06 2022-08-03 Arthrosi Therapeutics, Inc. CRYSTALLINE FORMS OF A COMPOUND FOR THE TREATMENT OR PREVENTION OF GOUT OR HYPERURICAEMIA
JP7528080B2 (ja) 2018-12-06 2024-08-05 アースローシ セラピューティクス,インク. 痛風または高尿酸血症を処置または予防するための方法
JPWO2020246528A1 (enExample) * 2019-06-04 2020-12-10
PE20240241A1 (es) * 2021-06-15 2024-02-16 Lg Chemical Ltd Una composicion farmaceutica que comprende acido 1-(3-ciano-1-isopropil-indol-5-il)pirazol-4-carboxilo
CN115252567A (zh) * 2022-07-08 2022-11-01 广西纯正堂制药有限公司 非布司他渗透泵缓释片及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1478759A (en) 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US5286497A (en) 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
US5573776A (en) 1992-12-02 1996-11-12 Alza Corporation Oral osmotic device with hydrogel driving member
US5544163A (en) 1994-03-08 1996-08-06 Excel, Inc. Expandable telecommunications system
US7361676B2 (en) 2002-03-28 2008-04-22 Teijin Limited Solid preparation containing single crystal form
EP1757610B1 (en) 2004-06-14 2011-06-08 Nippon Chemiphar Co., Ltd. Condensed pyrimidine derivative and xanthine oxidase inhibitor
CA2621038A1 (en) 2005-10-07 2007-04-19 Astellas Pharma Inc. Triarylcarboxylic acid derivative
MX2009007680A (es) * 2007-01-19 2011-08-03 Takeda Pharmaceuticals North America Inc Metodos para prevenir o reducir el numero de expansiones graduales de gota utilizando inhibidores de oxidoreductasa de xantina y agentes anti-inflamatorios.
EP2415771B1 (en) 2009-03-31 2013-07-31 Kissei Pharmaceutical Co., Ltd. Indolizine derivative and use thereof for medical purposes
CN101773498B (zh) * 2009-12-30 2012-06-20 青岛黄海制药有限责任公司 一种含有非布司他的口服缓控释制剂的制备方法
MY167126A (en) * 2010-06-16 2018-08-13 Takeda Pharmaceuticals Usa Inc Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
MX339452B (es) 2010-06-16 2016-05-27 Teijin Pharma Ltd Tableta con nucleo recubierto de liberacion controlada.
CN102641255A (zh) * 2012-05-08 2012-08-22 南方医科大学 一种治疗痛风的非布索坦渗透泵控释片及其制备方法

Similar Documents

Publication Publication Date Title
JP2016520133A5 (enExample)
RU2011143741A (ru) Производное индолизина и его применение в медицинских целях
JP2016512520A5 (enExample)
PH12019500395A1 (en) Amino-pyrrolopyrimidinone compounds and methods of use thereof
JP2011513305A5 (enExample)
JP2016515561A5 (enExample)
JP2013531029A5 (enExample)
JP2013528655A5 (enExample)
JP2016518437A5 (enExample)
JP2012508252A5 (enExample)
JP2014504622A5 (enExample)
JP2012184234A5 (enExample)
JP2017537940A5 (enExample)
JP2012041349A5 (enExample)
JP2015522650A5 (enExample)
MX359200B (es) Inhibidores de cinasa.
JP2013508288A5 (enExample)
JP2017504635A5 (enExample)
JP2016507575A5 (enExample)
MY195675A (en) A Group of Compounds used for the Treatment or Prevention of Hyperuricemia or Gout
JP2013063968A5 (enExample)
JP2018533593A5 (enExample)
JP2015521156A5 (enExample)
JP2017510660A5 (enExample)
RU2016142611A (ru) Пролекарственные средства ингибиторов обратной транскриптазы вич